Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:356-362
Published online before print January 2, 2008, doi: 10.1161/CIRCULATIONAHA.107.711523
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/3/356    most recent
CIRCULATIONAHA.107.711523v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, M.
Right arrow Articles by Peterson, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, M.
Right arrow Articles by Peterson, E. D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
*Coronary Artery Bypass Surgery
Related Collections
Right arrow Catheter-based coronary interventions: stents
Right arrow CV surgery: coronary artery disease
Right arrowRelated Article

(Circulation. 2008;117:356-362.)
© 2008 American Heart Association, Inc.


Cardiovascular Surgery

Mayo Clinic Risk Score for Percutaneous Coronary Intervention Predicts In-Hospital Mortality in Patients Undergoing Coronary Artery Bypass Graft Surgery

Mandeep Singh, MD, MPH; Bernard J. Gersh, MB, ChB; Shuang Li, MS; John S. Rumsfeld, MD; John A. Spertus, MD, MPH; Sean M. O’Brien, PhD; Rakesh M. Suri, MD, DPhil; Eric D. Peterson, MD, MPH

From the Division of Cardiovascular Diseases (M.S., B.J.G., R.M.S.), Mayo Clinic, Rochester, Minn; Duke Clinical Research Institute (S.L., S.M.O., E.D.P.), Durham, NC; Mid America Heart Institute/UMKC (J.A.S.), Kansas City, Mo; and Denver VA Medical Center (J.S.R.), Denver, Colo.

Reprint requests to Mandeep Singh, MD, MPH, Division of Cardiovascular Diseases, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Received April 29, 2007; accepted October 17, 2007.

Background— Current risk models predict in-hospital mortality after either coronary artery bypass graft surgery or percutaneous coronary interventions separately, yet the overlap suggests that the same variables can define the risks of alternative coronary reperfusion therapies. Our goal was to seek a preprocedure risk model that can predict in-hospital mortality after either percutaneous coronary intervention or coronary artery bypass graft surgery.

Methods and Results— We tested the ability of the recently validated, integer-based Mayo Clinic Risk Score (MCRS) for percutaneous coronary intervention, which is based solely on preprocedure variables (age, creatinine, ejection fraction, myocardial infarction ≤24 hours, shock, congestive heart failure, and peripheral vascular disease), to predict in-hospital mortality among 370 793 patients in the Society of Thoracic Surgeons database undergoing isolated coronary artery bypass graft surgery from 2004 to 2006. For the Society of Thoracic Surgeons coronary artery bypass graft surgery population studied, the median age was 66 years (quartiles 1 to 3, 57 to 74 years), with 37.2% of patients ≥70 years old. A high prevalence of comorbid conditions, including diabetes mellitus (37.1%), hypertension (80.5%), peripheral vascular disease (15.3%), and renal disease (creatinine ≥1.4 mg/dL; 11.8%), was present. A strong association existed between the MCRS and the observed mortality in the Society of Thoracic Surgeons database. The in-hospital mortality ranged between 0.3% (95% confidence interval 0.3% to 0.4%) with a score of 0 on the MCRS and 33.8% (95% confidence interval 27.3% to 40.3%) with an MCRS score of 20 to 24. The discriminatory ability of the MCRS was moderate, as measured by the area under the receiver operating characteristic curve (C-statistic=0.715 to 0.784 among various subgroups); performance was inferior to the Society of Thoracic Surgeons model for most categories tested.

Conclusions— This model, which is based on 7 preprocedure risk variables, may be useful for providing patients with individualized, evidence-based estimates of procedural risk as part of the informed consent process before percutaneous or surgical revascularization.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 331-332. [Extract] [Full Text]



This article has been cited by other articles:


Home page
NEJMHome page
M. Pocar, F. Donatelli, A. Moneta, H. Tomoda, J. A. Tayek, J. R. Arnold, A. P. Banning, S.-J. Park, D.-W. Park, and Y.-H. Kim
Stents versus Bypass Grafting for Left Main Coronary Artery Disease
N. Engl. J. Med., July 24, 2008; 359(4): 423 - 425.
[Full Text] [PDF]


Home page
CirculationHome page
T. B. Ferguson Jr
On the Evaluation of Intervention Outcome Risks for Patients With Ischemic Heart Disease
Circulation, January 22, 2008; 117(3): 333 - 335.
[Full Text] [PDF]